Organic compounds -- part of the class 532-570 series – Organic compounds – Chalcogen in the nitrogen containing substituent
Patent
1986-06-24
1988-07-19
Raymond, Richard L.
Organic compounds -- part of the class 532-570 series
Organic compounds
Chalcogen in the nitrogen containing substituent
549243, 560 28, 560 29, 560159, 564428, C07D26534
Patent
active
047586613
ABSTRACT:
(+)-trans-1a,2,3,4a,5,6-Hexahydro-9-hydroxy-4-propyl-4H-naphth[1,2-b]-1,4-o xazine is elaborated by a series of process steps that retain the enantiomeric purity of the starting material, D-aspartic acid. The product is a direct acting dopaminergic agent, useful in the treatment of Parkinson's disease.
REFERENCES:
patent: 4420480 (1983-12-01), Jones et al.
J. Org. Chem., 50, 3619, (1985), Nordlander et al.
J. Org. Chem., 46, 2431, (1981), McClure et al.
J. Org. Chem., 48, 2675, (1983), McClure et al.
J. Med. Chem., 27, 1607, (1984), Jones et al.
Eur. J. Med. Chem. Chim. Ther, 20,(3), 247-250, (1985).
Larsen Robert D.
Mathre David J.
Melillo David G.
Merck & Co. , Inc.
Nicholson William H.
Raymond Richard L.
Sudol Michael C.
LandOfFree
Chiral synthesis of (+)-trans-1a,2,3,4a,5,6-hexahydro-9-hydroxy- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chiral synthesis of (+)-trans-1a,2,3,4a,5,6-hexahydro-9-hydroxy-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chiral synthesis of (+)-trans-1a,2,3,4a,5,6-hexahydro-9-hydroxy- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-598205